- Report
- October 2024
- 181 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- April 2024
- 160 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- September 2024
- 158 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- August 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- July 2024
- 200 Pages
Brazil
From €5679EUR$5,950USD£4,758GBP
- Report
- June 2021
- 60 Pages
India
From €5679EUR$5,950USD£4,758GBP
- Report
- November 2023
- 176 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- September 2021
- 169 Pages
Global
From €3543EUR$3,712USD£2,968GBP
Veterinary Artificial Insemination (AI) is a reproductive technology used in animal healthcare/veterinary to assist in the breeding of animals. It is a process in which semen is collected from a male animal and then artificially introduced into the reproductive tract of a female animal. AI is used to improve the genetic quality of the offspring, increase the number of offspring, and reduce the cost of breeding. AI can also be used to introduce new genetic material into a population, such as introducing new traits or improving existing traits.
AI is used in a variety of animal species, including cattle, horses, sheep, goats, pigs, and poultry. AI is a safe and effective method of breeding, and it is becoming increasingly popular in the animal healthcare/veterinary industry.
Some companies in the Veterinary Artificial Insemination market include Genus plc, Cogent Breeding Ltd, Select Sires Inc., and ABS Global Inc. Show Less Read more